statistiche ricercatore

Nome	#
Anthracycline-based chemotherapy in extraskeletal myxoid chondrosarcoma: a retrospective study	173
Identification of a gene expression driven progression pathway in Myxoid liposarcoma	149
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment	143
Identification of SRF-E2F1 fusion transcript in EWSR-negative myoepithelioma of the soft tissue	138
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient [3]	129
Analysis of receptor tyrosine kinases (RTKs) and downstream pathways in chordomas	119
Is autophagy rather than apoptosis the regression driver in imatinib-treated gastrointestinal stromal tumors?	110
Patient-derived solitary fibrous tumour xenografts predict high sensitivity to doxorubicin/dacarbazine combination confirmed in the clinic and highlight the potential effectiveness of trabectedin or eribulin against this tumour	89
High-grade sarcomatous overgrowth in solitary fibrous tumors : a clinicopathologic study of 10 cases	82
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs)	78
A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient	53
Totale	1.263

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	289	30	16	16	40	18	43	44	18	26	29	7	2
2020/2021	173	4	7	14	5	16	12	19	15	26	18	21	16
2021/2022	154	11	15	6	6	11	6	15	8	9	9	7	51
2022/2023	214	31	31	27	29	12	38	2	7	27	3	6	1
2023/2024	240	7	10	7	9	46	21	24	20	13	21	28	34
2024/2025	4	4	0	0	0	0	0	0	0	0	0	0	0
Totale													1.263

IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca